RTW Biotech Opportunities (LON:RTW – Get Free Report) shares were up 0.9% during mid-day trading on Tuesday . The company traded as high as GBX 2.25 and last traded at GBX 2.24. 233,452 shares traded hands during mid-day trading, a decline of 72% from the average daily volume of 822,817 shares. The stock had previously closed at GBX 2.22.
RTW Biotech Opportunities Price Performance
The business has a fifty day moving average of GBX 2.19 and a two-hundred day moving average of GBX 2.13. The company has a debt-to-equity ratio of 20.05, a quick ratio of 0.81 and a current ratio of 0.15. The firm has a market capitalization of £7.57 million, a price-to-earnings ratio of 0.04 and a beta of 1.24.
About RTW Biotech Opportunities
RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Bio invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives. RTW Bio is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.
See Also
- Five stocks we like better than RTW Biotech Opportunities
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
